Ruiz-Botero Felipe, Rodríguez-Guerrero Juliet T
Centro de investigación en anomalías congénitas y enfermedades raras, Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia.
Escuela de Medicina, Facultad de Salud, Universidad del Valle, Cali, Colombia.
Rev Chil Pediatr. 2017;88(4):524-528. doi: 10.4067/S0370-41062017000400013.
The ataxia telangiectasia syndrome (AT) is a genetic disease with an autosomal recessive inheritance pattern, with multisystem involvement and a broad clinical spectrum. It is caused by the mutation of the ATM gene, causing reduction or absence of the ATM proteinkinase, altering processes in the cell cycle, DNA repair and apoptosis. The objective of this article is to report the case of a patient with ataxia telangiectasia syndrome, caused by a mutation not previously reported in the literature.
A 14 year-old patient native to Colombia, with classic clinical and phenotypical manifestations of AT syndrome, which started at 6 years of age with pondostatural alteration, recurrent respiratory infections, oculocutaneus telangiectasias and progressive neurological disorder that included: regression in her psychomotor development, ataxia and oculomotor apraxia. ATM gene sequencing is performed evidencing a homozygous mutation not reported in literature.
In Latin America are sparse the number of reports of patients with ataxia telangiectasia and only few of these describe their molecular findings. Molecular studies allow the diagnosis and a better orientation in the management and prognosis of patients with neurodegenerative diseases. The report of undescribed molecular variants is of great importance to establish the etiology of such diseases in diverse population groups, such as the countries of Latin America.
共济失调毛细血管扩张症(AT)是一种常染色体隐性遗传模式的遗传病,累及多系统,临床谱广。它由ATM基因突变引起,导致ATM蛋白激酶减少或缺失,改变细胞周期、DNA修复和细胞凋亡过程。本文目的是报告一例由文献中未先前报道的突变引起的共济失调毛细血管扩张症患者病例。
一名14岁的哥伦比亚患者,有AT综合征的典型临床和表型表现,6岁起出现身材发育异常、反复呼吸道感染、眼皮肤毛细血管扩张以及进行性神经障碍,包括精神运动发育倒退、共济失调和眼球运动失用。进行了ATM基因测序,发现了文献中未报道的纯合突变。
拉丁美洲共济失调毛细血管扩张症患者的报告数量稀少,且其中仅有少数描述了分子学发现。分子研究有助于神经退行性疾病患者的诊断以及在管理和预后方面提供更好的指导。未描述的分子变异报告对于确定拉丁美洲等不同人群中此类疾病的病因非常重要。